by Salomi LBSP | Jun 6, 2025 | News
A new collaboration between TNO, Proefdiervrij, and pharmaceutical company Galapagos, called MechPath, is accelerating the transition to animal-free drug development. By combining patient data, lab-based human cell models, and artificial intelligence, the MECHanistic...
by Bilyana LBSP | Jun 6, 2025 | News
Is repeatedly complimenting a colleague’s outfit appropriate, or could it cross a line? This thought-provoking question set the tone for the first-ever meeting of the Works Council Community at Leiden Bio Science Park, opening up conversations around workplace...
by Bilyana LBSP | Jun 5, 2025 | News
As part of the European Medicines Agency’s (EMA) EU-Competitiveness initiative, representatives from the agency visited Leiden Bio Science Park for an in-depth conversation with the local life sciences ecosystem. The goal: to raise awareness of regulatory support...
by Salomi LBSP | Jun 3, 2025 | News
A joint effort between Leiden University’s Professor Ubbink’s lab and ZoBio’s Assay Development and Screening team has advanced fragment-based drug discovery targeting membrane proteins. Supported by a Dutch Research Council (NWO) AES grant, the...
by Salomi LBSP | Jun 3, 2025 | News
Leyden Labs has secured €20 million in financing from the European Investment Bank (EIB), supported by HERA Invest under the EU’s InvestEU programme. The funding will support the clinical development of Leyden Labs’ PanFlu nasal spray, an intranasal antibody therapy...
by Salomi LBSP | Jun 2, 2025 | News
Researchers at Leiden University Medical Center (LUMC), in collaboration with Erasmus MC and the Oncode Institute, have developed a novel vaccine targeting non-small cell lung cancer (NSCLC). This vaccine aims to expose cancer cells that have evaded the immune system,...